Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients
about
Towards tumor immunodiagnosticsCytokine-Induced Modulation of Colorectal CancerGenetic instability in the tumor microenvironment: a new look at an old neighborFrom mice to humans: developments in cancer immunoeditingIL15 and T-cell Stemness in T-cell-Based Cancer ImmunotherapyCopy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosisExploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.Balancing the innate immune system in tumor development.NK cells require IL-28R for optimal in vivo activityThe Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor TypesFusobacterium nucleatum and T Cells in Colorectal Carcinoma.Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening.Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC).MicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cellsImmunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destructionTethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cellsTumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases.Shaping of an effective immune microenvironment to and by cancer cells.Emerging cytokine networks in colorectal cancer.An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies.Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps.Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis.Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation.Functional impairment of infiltrating T cells in human colorectal cancer.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.CIS is a potent checkpoint in NK cell-mediated tumor immunity.The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis.Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells.Tissue-resident lymphocytes: sentinel of the transformed tissueCharacterization of cytokinome landscape for clinical responses in human cancersCIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany.Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.Discovery and application of immune biomarkers for hematological malignancies.Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.Tissue-Resident Cytolytic Innate Lymphocytes in Cancer.A Novel Immune Marker Model Predicts Oncological Outcomes of Patients with Colorectal Cancer.
P2860
Q26738691-F5CF51A1-9572-4B39-A3E3-7134605F4CEEQ26752374-A5EA68EB-F5A5-4869-8FCD-52A89D937442Q26801374-E27BED90-EA04-4F72-89B6-EDDE62C8ED12Q28088304-625A9E08-104D-4998-B971-CAEDEB991FD1Q28088543-F06AF017-7D92-42C7-A773-934AD5DA6864Q34338284-BDB80053-4A57-4A1D-95FA-F221A0C69AB9Q35011470-28D9E2C4-FE31-4741-9210-45F2B3A0E199Q35236394-B58BC8A5-9904-496A-9ADF-DFDD43654617Q35590214-BDE85650-A0E6-4A6A-9404-0096D6B39E0FQ35785160-05FBC76D-F4F3-4E67-B1CE-68E72A2E34B1Q35956384-749427DB-E01C-457F-9CAC-D57F1A6EDCABQ36086751-29FC964F-7161-4E46-B2F1-3233705F4A0EQ36256382-31186E65-E6C2-45A1-9976-5C24F1FC7FE5Q37147870-9150D5B0-EE13-48E7-8F52-58575FD7A3BBQ37267893-A437C06C-DF93-4AB7-952E-1B6916F11161Q37364736-2C76199D-0A5F-4548-92ED-0FE0307C6F6DQ37474007-9F7B10AA-3B4B-4F22-96FC-91F96DBA57F0Q37688202-79B0450D-ED56-4A1F-941C-5001F61D536BQ37721209-CE4DE2F2-C88F-4852-A932-924A233B717CQ38238941-86661318-F50B-4A86-8B3C-8F636CDBD57AQ38584430-4108DC1B-98EF-4C8B-8CA7-C748BEF21932Q38705693-45B5CFAE-C5B7-4641-A728-831CBE556949Q38845812-E3EC4E65-FA68-4CDE-B692-106AA50AC454Q38875021-62B15D8A-9788-4B16-BE14-C56FECB10DCDQ38892904-A7AF1853-7A53-4A07-97CD-465294B1ACC7Q39079676-90875F90-693D-41B3-A7A2-90F2F5F0A8C6Q39313889-FAD19134-EE8D-4082-ACA8-BAC52484BC87Q39744193-719C7386-211D-4B79-9B0C-628B6686B309Q39970530-695D2FAA-A846-42C5-B859-5607B206625DQ40244514-3FE5955D-66E1-414C-ABCA-9EACCEA2E8F9Q40746149-0C9FD270-1583-470C-BE17-60335AF332BAQ42114048-07DB08AE-0C1F-494F-9E53-6B3DD2EBBD44Q42350320-AA91C6FF-3E44-400B-8216-84819FAE2E82Q42818804-394709E8-BCFB-4FA3-B482-9B32C221FE7EQ44549404-8FCC8D1A-6786-4D05-A320-19DC1E99D1C3Q45864012-F0EBE0A6-FF9A-487B-91E6-947441F457CBQ47681393-AFB21DE6-3D8C-4002-9C00-45B561AE4E39Q47784299-BE071634-B770-4358-B06C-A69623DEB918Q50133227-2413CFCA-109F-4B9F-A1E4-091F5787D33CQ50770591-D0C258F8-F345-447B-98D1-6448CC54B9D2
P2860
Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients
description
article
@en
im März 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2014
@uk
name
Functional Network Pipeline Re ...... nd Survival of Cancer Patients
@en
Functional Network Pipeline Re ...... nd Survival of Cancer Patients
@nl
type
label
Functional Network Pipeline Re ...... nd Survival of Cancer Patients
@en
Functional Network Pipeline Re ...... nd Survival of Cancer Patients
@nl
prefLabel
Functional Network Pipeline Re ...... nd Survival of Cancer Patients
@en
Functional Network Pipeline Re ...... nd Survival of Cancer Patients
@nl
P2093
P2860
P50
P1476
Functional network pipeline re ...... nd survival of cancer patients
@en
P2093
Amelie M Bilocq
Amos Kirilovsky
Anne Berger
Arash Rafii
Bernhard Mlecnik
Franck Pagès
Gabriela Bindea
Helen K Angell
Lucie Lafontaine
Maria Stella Sasso
P2860
P304
P356
10.1126/SCITRANSLMED.3007240
P407
P577
2014-03-01T00:00:00Z